Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
07/02/1991 | CA1285561C Naphthoxazines |
07/02/1991 | CA1285488C Pharmaceutical formulation containing indomethacin |
07/02/1991 | CA1285482C Sustained-release pharmaceutical preparation |
06/28/1991 | CA2032973A1 Aminopyridinylmethanols and aminomethylpyridinamines and related compounds, a process for their preparation and their use as medicaments |
06/27/1991 | WO1991009019A1 Substituted oxophthalazinyl acetic acids and analogs thereof |
06/27/1991 | WO1991008740A1 The use of gaba-b selective agonists as anti-tussive agents |
06/27/1991 | CA2032984A1 Thienobenzoxepin- and naphthothiophene-derivatives, a process and intermediates for their preparation and their use as medicaments |
06/27/1991 | CA2032925A1 Analgesic and anti-inflammatory medicine |
06/26/1991 | EP0434561A2 1-Naphthyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them |
06/26/1991 | EP0434560A1 New derivatives of substituted aminoacids, process for their preparation and pharmaceutical compositions containing them |
06/26/1991 | EP0434369A1 New benzodiazepine analogs |
06/26/1991 | EP0434364A2 Benzodiazepine analogs for treating panic syndrome and for directly inducing analgesia |
06/26/1991 | EP0434360A1 New benziodiazepine analogs |
06/26/1991 | EP0434249A2 Benzofuran derivatives |
06/26/1991 | EP0434202A1 Azabicyclo amides and esters as 5-HT3 receptor antagonists |
06/26/1991 | EP0434173A2 Use of NMDA receptor antagonists for treatment of chronic neurodegenerative diseases |
06/26/1991 | EP0434094A1 Methods of using 2-isopropyl-2-phenylaminovaleronitriles immunosuppresants and vasodilators |
06/26/1991 | EP0434057A2 Indolocarbazole derivatives, processes for their preparation and their use |
06/26/1991 | EP0433848A1 Crystalline magnesium valproate and a method for the preparation thereof |
06/25/1991 | US5026868 Indenyl imidazoles |
06/25/1991 | US5026858 Used for treating nausea, vomating, gastrointestinal disorders and centarl nervous system |
06/25/1991 | US5026733 Brain function-improving medicine |
06/25/1991 | US5026717 Glutamate inhibitors |
06/25/1991 | US5026716 Administering trifluoromethylphenyl-tetrahydropyridine derivatives |
06/25/1991 | US5026711 Prevention and treatment of cardiovascular disorders and infections states; anxiolytic and anti-allergic agents |
06/25/1991 | US5026704 Benzo[f]quinoxaline-2,3(1H,4H)-diones |
06/25/1991 | US5026701 Morpholine compounds, compositions and use |
06/25/1991 | US5026556 Buprenorphine in carrier comprises lower alkyl diols or triols and a polar lipid |
06/25/1991 | CA1285277C Process for preparing ergoline derivatives |
06/24/1991 | WO1991009858A1 NEW-β-CARBOLINS, PROCESS FOR PREPARING THEM AND THEIR USE IN DRUGS |
06/24/1991 | CA2050917A1 Beta-carbolines, process for their production and their use in pharmaceutical agents |
06/23/1991 | CA2032956A1 Spray drying process for making pharmaceutical powder compositions directly compressible into tablets |
06/22/1991 | CA2033038A1 Methods of using 2-isopropyl-2-phenylaminovaleronitriles immunosuppressants and vasodilator |
06/21/1991 | CA2032735A1 Substituted amino-acid derivatives; process for preparing the same and pharmaceutical compositions containing them |
06/21/1991 | CA2032713A1 Novel (1-naphthyl)piperazine derivatives; process for preparing the same and pharmaceutical compositions containing them |
06/20/1991 | WO1991008738A1 Compositions and method for treating painful, inflammatory or allergic disorders |
06/19/1991 | WO1991009032A1 Piperidine compounds and a pharmaceutical composition |
06/19/1991 | EP0433163A2 Process for the preparation of imidazobenzodiazepines and their salts |
06/19/1991 | EP0433113A1 Stabilization and maintenance of the nerve growth factor biological activity by use of natural gangliosides or derivatives thereof |
06/19/1991 | EP0433112A1 Modified gangliosides and the functional derivatives thereof |
06/19/1991 | EP0433043A1 Medicaments |
06/19/1991 | EP0432945A1 A transdermal delivery system for treatment of cocaine and heroin addiction |
06/19/1991 | EP0432893A2 Benzoxazine derivatives, their preparation and pharmaceutical compositions containing them |
06/19/1991 | EP0432856A2 Use of rolipram in the treatment of dementia |
06/19/1991 | EP0432719A1 Alkylamino- and alkylaminoalkyl diarylketones, a process for their preparation and their use as medicaments |
06/19/1991 | EP0432648A2 Isatine derivatives, their preparation and use |
06/19/1991 | EP0432510A1 Process for the preparation of genetic vectors for the nerve growth factor expression in eukaryotic cells |
06/19/1991 | EP0282495B1 Xylometazolin-containing pharmaceuticals |
06/19/1991 | CN1052306A Pharmaceutically active cns compounds |
06/19/1991 | CN1052305A Pyridine derivatives, pharmaceutical compositions containing them and process for preparing same |
06/19/1991 | CA2071480A1 Piperidine compounds and a pharmaceutical composition |
06/19/1991 | CA2032427A1 Benzodiazepines analogs |
06/19/1991 | CA2032226A1 Benzodiazepine analogs |
06/19/1991 | CA2032222A1 Benzodiazepine analogs doe treating panic syndrome and for directly inducing analgesia |
06/18/1991 | US5025035 Method of treating depression |
06/18/1991 | US5025033 Cholinesterase inhibitors for treating brain disorders |
06/18/1991 | US5025022 Method of treating or preventing schizophrenia and/or psychosis using S-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamides and thiobenzamides |
06/18/1991 | US5025011 Calcium-antigonist and beta-blocking properties; antihypertensives; vasodilators |
06/18/1991 | US5025009 Novel benzazepine derivatives |
06/18/1991 | CA1284997C 5-aryl-2,4-dialkyl-3h-1,2,4-triazole-3-thiones and their use as antidepressants |
06/18/1991 | CA1284952C Use of specific n-methyl-d-aspartate receptor antagonists in the prevention and treatment of neurodegeneration |
06/18/1991 | CA1284950C Method for using diltiazem, verapamil or nifedipine for treating stroke |
06/15/1991 | CA2032176A1 Alkylamino- and alkylaminoalkyl diarylketones, a process for their preparation and their use as medicaments |
06/14/1991 | CA2032049A1 Medicaments |
06/13/1991 | WO1991009014A1 Muscarinic receptor antagonists |
06/13/1991 | WO1991009013A1 Muscarinic receptor antagonists |
06/13/1991 | WO1991008298A2 Fusion proteins consisting of a ligand binding protein and a stable plasma protein |
06/13/1991 | WO1991008211A1 IMIDAZO[1,2-a]PYRIDINYLALKYL COMPOUNDS FOR TREATMENT OF NEUROTOXIC INJURY |
06/13/1991 | WO1991008205A1 N-acyl-substituted azacyclic compounds, processes for their preparation, and their use as pharmaceuticals |
06/13/1991 | WO1991007968A1 Hydrochloride 2,3,3a,4,5,6-hexahydro-8-cyclohexyl-1h-pyrazino (3,2,1-j,k)carbazol, method of obtaining it and a pharmaceutical preparation of antidepressive action based on it |
06/13/1991 | WO1991007955A1 Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders |
06/13/1991 | CA2032004A1 Method for treatment of cocaine and heroin addiction comprising transdermal delivery of buprenorphine |
06/12/1991 | EP0432099A2 Hydrogenated nitrogen containing heterocycles |
06/12/1991 | EP0432039A2 Antipsychotic drug comprising an acylaminoacid |
06/12/1991 | EP0431663A1 Stabilized solutions of psychotropic agents |
06/12/1991 | EP0431659A1 Pharmaceutical compositions of tebufelone |
06/12/1991 | EP0431580A2 Substituted cyclohexanols as central nervous system agents |
06/12/1991 | EP0431579A2 Substituted cyclohexenes as central nervous system agents |
06/12/1991 | EP0431371A1 3-Aminopyrroles, process for this preparation and their use as medicaments |
06/12/1991 | CN1052116A Process for preparing triazolyl thioamide derivatives |
06/12/1991 | CA2031898A1 Chemical compounds |
06/12/1991 | CA2024968A1 Antidementia drug |
06/11/1991 | US5023272 Use of 5-phenyl-2-furan esters and amides as antiepileptic agents |
06/11/1991 | US5023268 Therapy for cerebral edema |
06/11/1991 | US5023266 Method of treatment of psychotic disorders |
06/11/1991 | US5023244 Anti-dementia agents |
06/11/1991 | US5023238 By amino-tricyano-propene |
06/09/1991 | CA2031682A1 Hydrogenated nitrogen heterocycles |
06/08/1991 | WO1991009006A1 New bicyclic amino-substituted compounds |
06/08/1991 | CA2046292A1 Bicyclic amino-substituted compounds |
06/05/1991 | WO1991007963A1 Glycyl-p-amino-pyridine for the treatment of senile dementia states |
06/05/1991 | EP0430800A1 Substituted benzothiazolinones, process for their preparation and pharmaceutical compositions containing them |
06/05/1991 | EP0430771A1 Isoindolone derivatives, their preparation and their use as intermediates for the preparation of substance P antagonists |
06/05/1991 | EP0430709A2 Benzthiophen derivatives |
06/05/1991 | EP0430414A1 Morphine hydrochloride preparation for rectal administration |
06/05/1991 | EP0430287A2 Sustained-release drug dosage units |
06/05/1991 | EP0430201A2 Aminocarbonylcarbamates related to physostigmine, a process for their preparation and their use as medicaments |
06/05/1991 | EP0430190A2 New tricyclic compounds |
06/05/1991 | EP0430114A2 Hexahydro-1H-quino[4,3,2-ef][1,4]benzoxazepines and related compounds, a process and intermediates for their preparation and their use as medicaments |
06/05/1991 | EP0430035A2 Use of benzothiazepine for the preparation of a medicament for treating seizures |